Literature DB >> 20004177

Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro.

Min Yang1, Rui Zhang, Ming Yan, Zhengxu Ye, Wei Liang, Zhuojing Luo.   

Abstract

Dye exclusion is a valuable technique to isolate cancer stem cells (CSCs) based on an ability of stem cell to efflux fluorescent DNA-binding dye, especially for tumors without unique surface markers. It has been proven that side population (SP) cells that exclude Hoechst 33342 dye are enriched with stem-like cells in several cancer cell lines. In this study, we isolated and characterized SP cells from human Ewing's sarcoma cell line SK-ES-1 in vitro. SP cells were detected in SK-ES-1 and comprised 1.2% of total cell population. Only SP cells had the capacity to regenerate both SP and non-SP cells. The proliferation rates were similar between SP and non-SP cells. However, the clonogenicity and invasiveness of SP cells were significantly higher than that of non-SP cells. Further characterization of this SP phenotype presented other properties. SP cells exhibited increased multi-drug resistance and the ATP binding cassette protein (ABC) transporters were up-regulated in SP population. These findings suggest that SP cells derived from Ewing's sarcoma play the critical role in tumor metastasis and recurrence and might be an ideal target for clinical therapy. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004177     DOI: 10.1016/j.bbrc.2009.12.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

Review 2.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

Review 3.  An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Authors:  Mojdeh Safari; Alireza Khoshnevisan
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Osteosarcoma cells differentiate into phenotypes from all three dermal layers.

Authors:  Scott Russinoff; Sara Miran; Ashok L Gowda; Paul A Lucas
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

5.  Endosialin expression in side populations in human sarcoma cell lines.

Authors:  Cecile Rouleau; Jose Sancho; Juanita Campos-Rivera; Beverly A Teicher
Journal:  Oncol Lett       Date:  2011-11-14       Impact factor: 2.967

6.  ROCK1-PredictedmicroRNAs Dysregulation Contributes to Tumor Progression in Ewing Sarcoma.

Authors:  G M Roberto; L E A Delsin; G M Vieira; M O Silva; R G Hakime; N F Gava; E E Engel; C A Scrideli; L G Tone; María Sol Brassesco
Journal:  Pathol Oncol Res       Date:  2017-12-21       Impact factor: 3.201

Review 7.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

8.  Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line.

Authors:  Liang Deng; Dejian Li; Wenguang Gu; Aiguo Liu; Xiangyang Cheng
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

9.  Differential remodeling of extracellular matrices by breast cancer initiating cells.

Authors:  Anju M Raja; Shuoyu Xu; Shuangmu Zhuo; Dean C S Tai; Wanxin Sun; Peter T C So; Roy E Welsch; Chien-Shing Chen; Hanry Yu
Journal:  J Biophotonics       Date:  2015-01-19       Impact factor: 3.207

10.  Osteosarcoma: mouse models, cell of origin and cancer stem cell.

Authors:  Maria V Guijarro
Journal:  Postdoc J       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.